Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Gross Profit
Burning Rock Biotech Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Gross Profit
¥363.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Gross Profit
¥7.7B
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Gross Profit
¥5.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Gross Profit
¥4.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Gross Profit
¥14.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
44%
|
CAGR 10-Years
41%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Gross Profit
¥1.8B
|
CAGR 3-Years
53%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Gross Profit?
Gross Profit
363.2m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Gross Profit amounts to 363.2m CNY.
What is Burning Rock Biotech Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
22%
Over the last year, the Gross Profit growth was -4%. The average annual Gross Profit growth rates for Burning Rock Biotech Ltd have been 5% over the past three years , 22% over the past five years .